Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 1
2005 2
2007 1
2009 2
2010 2
2011 1
2012 1
2014 1
2015 3
2016 4
2017 3
2018 4
2019 1
2020 4
2021 4
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma.
Capone E, Perrotti V, Cela I, Lattanzio R, Togni L, Rubini C, Caponio VCA, Lo Muzio L, Colasante M, Giansanti F, Ippoliti R, Iacobelli S, Wick MJ, Spardy Burr N, Sala G. Capone E, et al. Among authors: giansanti f. Oral Oncol. 2024 Jan;148:106635. doi: 10.1016/j.oraloncology.2023.106635. Epub 2023 Nov 21. Oral Oncol. 2024. PMID: 37988837 Free article.
Aptamer-Driven Toxin Gene Delivery in U87 Model Glioblastoma Cells.
di Leandro L, Giansanti F, Mei S, Ponziani S, Colasante M, Ardini M, Angelucci F, Pitari G, d'Angelo M, Cimini A, Fabbrini MS, Ippoliti R. di Leandro L, et al. Among authors: giansanti f. Front Pharmacol. 2021 Apr 15;12:588306. doi: 10.3389/fphar.2021.588306. eCollection 2021. Front Pharmacol. 2021. PMID: 33935695 Free PMC article.
Taking Advantage of the Morpheein Behavior of Peroxiredoxin in Bionanotechnology.
Ardini M, Bellelli A, Williams DL, Di Leandro L, Giansanti F, Cimini A, Ippoliti R, Angelucci F. Ardini M, et al. Among authors: giansanti f. Bioconjug Chem. 2021 Jan 20;32(1):43-62. doi: 10.1021/acs.bioconjchem.0c00621. Epub 2021 Jan 7. Bioconjug Chem. 2021. PMID: 33411522 Free PMC article. Review.
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma.
Capone E, Lamolinara A, Pastorino F, Gentile R, Ponziani S, Di Vittorio G, D'Agostino D, Bibbò S, Rossi C, Piccolo E, Iacobelli V, Lattanzio R, Panella V, Sallese M, De Laurenzi V, Giansanti F, Sala A, Iezzi M, Ponzoni M, Ippoliti R, Iacobelli S, Sala G. Capone E, et al. Among authors: giansanti f. Cancers (Basel). 2020 Oct 15;12(10):2989. doi: 10.3390/cancers12102989. Cancers (Basel). 2020. PMID: 33076448 Free PMC article.
Antibody-Drug Conjugates: The New Frontier of Chemotherapy.
Ponziani S, Di Vittorio G, Pitari G, Cimini AM, Ardini M, Gentile R, Iacobelli S, Sala G, Capone E, Flavell DJ, Ippoliti R, Giansanti F. Ponziani S, et al. Among authors: giansanti f. Int J Mol Sci. 2020 Jul 31;21(15):5510. doi: 10.3390/ijms21155510. Int J Mol Sci. 2020. PMID: 32752132 Free PMC article. Review.
36 results